Financial results - KARDIOLINE S.R.L.

Financial Summary - Kardioline S.r.l.
Unique identification code: 21438640
Registration number: J40/6047/2007
Nace: 8622
Sales - Ron
8.592
Net Profit - Ron
232
Employee
The most important financial indicators for the company Kardioline S.r.l. - Unique Identification Number 21438640: sales in 2023 was 8.592 euro, registering a net profit of 232 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Kardioline S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 63.966 62.589 54.268 67.452 15.271 14.523 8.384 10.131 5.668 8.592
Total Income - EUR 63.966 62.589 54.287 67.588 15.278 14.737 10.852 17.242 5.668 24.342
Total Expenses - EUR 30.946 20.317 18.380 19.918 26.018 24.226 16.931 21.660 14.416 23.980
Gross Profit/Loss - EUR 33.019 42.272 35.906 47.671 -10.741 -9.489 -6.079 -4.419 -8.748 362
Net Profit/Loss - EUR 31.100 40.394 34.278 45.644 -11.199 -9.925 -6.360 -4.728 -8.927 232
Employees 0 0 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 52.1%, from 5.668 euro in the year 2022, to 8.592 euro in 2023. The Net Profit increased by 232 euro, from 0 euro in 2022, to 232 in the last year.

Check the financial reports for the company - Kardioline S.r.l.

Rating financiar

Financial Rating -
Kardioline S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Kardioline S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Kardioline S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Kardioline S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Kardioline S.r.l. - CUI 21438640

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 9.668 5.249 742 33.432 23.660 14.220 5.140 0 625 324
Current Assets 142.047 186.237 137.607 152.123 149.471 146.265 146.912 145.244 95.878 92.940
Inventories 869 876 867 853 837 821 805 787 0 0
Receivables 9.655 11.083 14.159 31.201 30.876 33.865 33.884 35.189 33.585 34.015
Cash 86.901 129.284 78.045 76.287 74.780 69.433 70.876 68.838 21.738 18.492
Shareholders Funds 54.310 95.158 34.706 79.763 67.100 55.876 48.457 42.654 -8.830 -8.571
Social Capital 89 90 89 88 86 84 83 81 81 81
Debts 89.904 96.328 103.643 106.342 106.571 104.609 103.639 102.590 105.333 101.835
Income in Advance 7.501 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 92.940 euro in 2023 which includes Inventories of 0 euro, Receivables of 34.015 euro and cash availability of 18.492 euro.
The company's Equity was valued at -8.571 euro, while total Liabilities amounted to 101.835 euro. Equity increased by 232 euro, from -8.830 euro in 2022, to -8.571 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Kardioline S.r.l.

Comments - Kardioline S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.